Literature DB >> 2049694

Acute allergic interstitial pneumonitis induced by hydrochlorothiazide.

P Biron1, J Dessureault, E Napke.   

Abstract

OBJECTIVE: To examine the clinical features of 4 unpublished cases and 26 published cases of acute allergic interstitial pneumonitis induced by hydrochlorothiazide (HCT). DATA SOURCES: The unpublished cases were found in the database of the Drug Adverse Reaction Program, Health Protection Branch, Department of National Health and Welfare, and the database of the Programme conjoint de pharmacovigilance, in Quebec. The published cases were retrieved from MEDLINE and EMBASE. STUDY SELECTION: Reported cases were selected if they were sufficiently documented. All published cases were selected because a differential diagnosis had been made in each one. DATA SYNTHESIS: The onset was acute and dramatic; the average time to onset of symptoms was 44 minutes. Sex was a predominant risk factor, since 27 (90%) of the 30 patients were women. The average age was 56 years; thus, most of the women were postmenopausal. Over two-thirds of the patients had one to three positive prechallenges or rechallenges, 3 of the 52 documented adverse events occurred after a voluntary rechallenge, some were life-threatening and necessitated mechanical ventilation, and 1 was fatal. Treatment was supportive; avoidance of HCT was the only prevention.
CONCLUSION: Acute allergic interstitial pneumonitis due to HCT is extremely rare and potentially fatal. Such a reaction can be diagnosed only if the clinician suspects it when presented with a case of unexplained acute pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049694      PMCID: PMC1335560     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  24 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

2.  Non-cardiogenic pulmonary edema after ingestion of chlorothiazide.

Authors:  F J Bowden
Journal:  BMJ       Date:  1989-03-04

3.  [Subacute pneumopathy caused by hydrochlorothiazide. Cytologic study of the broncho-alveolar lavage].

Authors:  Y Watrigant; B Wallaert; P Ramon; B Gosselin; W Peng; A B Tonnel
Journal:  Rev Mal Respir       Date:  1986       Impact factor: 0.622

4.  Non-cardiogenic pulmonary edema after oral ingestion of hydrochlorothiazide.

Authors:  E Alted; M Navarro; J A Cantalapiedra; J A Alvarez; M A Blasco; A Nuñez
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

5.  [Hydrochlorothiazide-induced lung edema with shock].

Authors:  F Caduff; H J Gloor
Journal:  Schweiz Med Wochenschr       Date:  1988-01-31

6.  Life-threatening reaction to thiazides.

Authors:  L Gould; C V Reddy; B Zen; B K Singh
Journal:  N Y State J Med       Date:  1980-12

7.  Hypovolemia and permeability pulmonary edema associated with anaphylaxis.

Authors:  R W Carlson; R C Schaeffer; V K Puri; A P Brennan; M H Weil
Journal:  Crit Care Med       Date:  1981-12       Impact factor: 7.598

Review 8.  Hydrochlorothiazide-induced acute pulmonary edema.

Authors:  M S Kavaru; M Ahmad; K N Amirthalingam
Journal:  Cleve Clin J Med       Date:  1990 Mar-Apr       Impact factor: 2.321

9.  Hydrochlorothiazide-induced pulmonary edema. Report of a case and review of the literature.

Authors:  R T Bell; M Lippmann
Journal:  Arch Intern Med       Date:  1979-07

10.  Hydrochlorothiazide-associated pulmonary edema.

Authors:  T J Anderson; Y Berthiaume; D Matheson; P Boiteau
Journal:  Chest       Date:  1989-09       Impact factor: 9.410

View more
  2 in total

1.  Recurrent hydrochlorothiazide-induced pulmonary edema.

Authors:  A Mas; R Jordana; J Vallés; M Cervantes
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 2.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.